|
Volumn 35, Issue 5, 2009, Pages 775-777
|
Pharmaceutical management through environmental product labeling in Sweden
|
Author keywords
Drug legislation; Environment; Hazard assessment; Human drugs; Risk assessment; Sewage water
|
Indexed keywords
AQUATIC ORGANISMS;
BIOACCUMULATION;
BIOCHEMISTRY;
BIOHAZARDS;
HAZARDS;
HEALTH CARE;
PUBLIC HEALTH;
RISK ASSESSMENT;
SEWAGE;
ENVIRONMENT;
ENVIRONMENTAL CLASSIFICATION SYSTEM;
ENVIRONMENTAL PRODUCTS;
HAZARD ASSESSMENT;
HUMAN DRUGS;
PREDICTED ENVIRONMENTAL CONCENTRATIONS;
PREDICTED NO-EFFECT CONCENTRATIONS;
SEWAGE WATER;
ENVIRONMENTAL IMPACT;
ATENOLOL;
CETIRIZINE;
CIPROFLOXACIN;
CODEINE;
DICLOFENAC;
FUROSEMIDE;
IBUPROFEN;
KETOPROFEN;
LOSARTAN;
METOPROLOL;
NAPROXEN;
PARACETAMOL;
SULFAMETHOXAZOLE;
TRAMADOL;
ANTHROPOGENIC SOURCE;
BIOACCUMULATION;
CLASSIFICATION;
CONCENTRATION (COMPOSITION);
DRUG;
ENVIRONMENTAL IMPACT;
HAZARD ASSESSMENT;
HEALTH CARE;
LEGISLATION;
PUBLIC HEALTH;
RESOURCE MANAGEMENT;
RISK ASSESSMENT;
SEWAGE;
WASTEWATER;
ARTICLE;
BIOACCUMULATION;
DRUG CLASSIFICATION;
DRUG INDUSTRY;
DRUG LEGISLATION;
ECOTOXICITY;
ENVIRONMENTAL IMPACT;
HAZARD ASSESSMENT;
PRIORITY JOURNAL;
RISK ASSESSMENT;
SWEDEN;
EURASIA;
EUROPE;
NORTHERN EUROPE;
SCANDINAVIA;
SWEDEN;
|
EID: 67349128006
PISSN: 01604120
EISSN: 18736750
Source Type: Journal
DOI: 10.1016/j.envint.2008.12.008 Document Type: Article |
Times cited : (37)
|
References (9)
|